Publications

Publications 2024

1. Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN). Cohen LE, Hansen CL, Andrew MK, McNeil SA, Vanhems P, Kyncl J, Domingo JD, Zhang T, Dbaibo G, Laguna-Torres VA, Draganescu A, Baumeister E, Gomez D, Raboni SM, Giamberardino HIG, Nunes MC, Burtseva E, Sominina A, Medić S, Coulibaly D, Salah AB, Otieno NA, Koul PA, Unal S, Tanriover MD, Mazur M, Bresee J, Viboud C, Chaves SS. J Infect Dis. 2024 Apr 12;229(4):999-1009.

2. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members. Khanafer NL, Fitzpatrick F, Barbut F, Krutova M, Davies K, Guery B, Vanhems P. Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):785-789.

3. Implementation of an antibiotic resistance surveillance tool in Madagascar, the TSARA project: a prospective, observational, multicentre, hospital-based study protocol. Elias C, Raad M, Rasoanandrasana S, Raherinandrasana AH, Andriananja V, Raberahona M, Moore CE, Randria M, Raskine L, Vanhems P, Babin FX. BMJ Open. 2024 Mar 19;14(3):e078504.

4. Characteristics of Hospitalized COVID-19 Patients at Admission and Factors Associated with Clinical Severity in Low- and Middle-Income Countries: An Observational Study. Abifadel M, Ahmmed K, Banu S, Camara I, Chowdhury F, Coulibaly D, Dabar G, Dananché C, Daw R, Hassan Z, Hervé M, Islam A, Komurian-Pradel F, Kouamé JP, Kouriba B, Najjar-Pellet J, Rakotonaivo A, Ranaivo-Rabetokotany F, Rasamoelina M, Rasolofoarison T, Riachi M, Saadatian-Elahi M, Samison L, Sanchez Picot V, Savané S, Thera I, Touré A, Vanhems P. Am J Trop Med Hyg. 2024 Feb 27:tpmd230456.

5. Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April-June 2020). Shirreff G, Huynh BT, Duval A, Pereira LC, Annane D, Dinh A, Lambotte O, Bulifon S, Guichardon M, Beaune S, Toubiana J, Kermorvant-Duchemin E, Chéron G, Cordel H, Argaud L, Douplat M, Abraham P, Tazarourte K, Martin-Gaujard G, Vanhems P, Hilliquin D, Nguyen D, Chelius G, Fraboulet A; EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling; Temime L, Opatowski L, Guillemot D.Sci Rep. 2024 Feb 14;14(1):3702

6. Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network. Young JJ, Mutch H, Rose AMC, Evans JMM; European COVID-19 Hospital Evaluation Writing Group. Eur J Public Health. 2024 Feb 5;34(1):181-189.

Publications 2023

1. Exploratory analysis of the knowledge, attitudes and perceptions of healthcare workers about arboviruses in the context of surveillance in the Republic of Guinea. Bangoura ST, Hounmènou CG, Sidibé S, Camara SC, Mbaye A, Olive MM, Camara A, Delamou A, Keita AK, Delaporte E, Khanafer N, Touré A. PLoS Negl Trop Dis. 2023 Dec 4;17(12):e0011814.

2. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022. Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O'Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above). Euro Surveill. 2023 Nov;28(47):2300187

3. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021. Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors). Euro Surveill. 2023 Nov;28(47):2300186.

4. Estimating the number of probable new SARS-CoV-2 infections among tested subjects from the number of confirmed cases. Diarra YM, Wimba PM, Katchunga PB, Bengehya J, Miganda B, Oyimangirwe M, Tshilolo L, Ahuka SM, Iwaz J, Étard JF, Écochard R, Vanhems P, Rabilloud M. BMC Med Res Methodol. 2023 Nov 17;23(1):272. 

5. Predictors of Death in Rifampicin Resistant Tuberculosis Patients Treated with the Short Course in Conakry, Guinea. Bangoura ST, Diallo BD, Diaby M, Camara A, Hounmenou CG, Magassouba AS, Kadio KJO, Vanhems P, Touré A, Khanafer N. Am J Trop Med Hyg. 2023 Nov 13:tpmd230190.

6. Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network. Young JJ, Mutch H, Rose AMC, Evans JMM; European COVID-19 Hospital Evaluation Writing Group. Eur J Public Health. 2023 Oct 27:ckad185.

7. Factors associated with long COVID-19 in a French multicentric prospective cohort study. Nagham Khanafer, Laeticia Henaff, Sabrina Bennia, Anne Termoz, Roland Chapurlat, Vanessa Escuret, Mathilde Proriol, Florence Duvert, Camille Menat, Catherine Planckaert, Nadège Trehet-Mandez, Mitra Saadatian-Elahi and Philippe Vanhems. Int J Environ Res Public Health. 2023 Aug 29;20(17):6678.

8. Predictors of severity of influenza-related hospitalizations:Results from the Global Influenza Hospital Surveillance Network (GIHSN). Cohen LE, Hansen CL, Andrew MK, McNeil SA, Vanhems P, Kyncl J, Díez Domingo J, Zhang T, Dbaibo G, Laguna-Torres VA, Draganescu A, Baumeister E, Gomez D, Raboni SM, Giamberardino HIG, Nunes MC, Burtseva E, Sominina A, Medić S, Coulibaly D, Ben Salah A, Otieno NA, Koul PA, Unal S, Durusu Tanriover M, Mazur M, Bresee J, Viboud C, Chaves SS. J Infect Dis. 2023 Aug 1:jiad303.

9. Burden of influenza in the elderly: a narrative review. Conrad A, Valour F, Vanhems P. Curr Opin Infect Dis. 2023 Aug 1;36(4):296-302.

10. Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform. Stuurman AL, Carmona A, Biccler J, Descamps A, Levi M, Baum U, Mira-Iglesias A, Bellino S, Hoang U, de Lusignan S, Bonaiuti R, Lina B, Rizzo C, Nohynek H, Díez-Domingo J; DRIVE Study Contributors. Front Public Health. 2023 Jul 20;11:1195409.

11. Influenza transmissibility among patients and health-care professionals in a geriatric short-stay unit using individual contact data. Gustin MP, Pujo-Menjouet L, Vanhems P. Sci Rep. 2023 Jun 29;13(1):10547.

12. Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004-2020). Saadatian-Elahi M, Henaff L, Elias C, Nunes MC, Hot A, Martin-Gaujard G, Escuret V, Amour S, Vanhems P. Vaccine. 2023 Jun 13:S0264-410X(23)00621-7

13. Point-of-Care Testing for SARS-CoV-2: A Prospective Study in a Primary Health Centre. Daniels R, Cottin J, Khanafer N. Diagnostics (Basel). 2023 May 28;13(11):1888.

14. Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network. Andrew MK, Pott H, Staadegaard L, Paget J, Chaves SS, Ortiz JR, McCauley J, Bresee J, Nunes MC, Baumeister E, Raboni SM, Giamberardino HIG, McNeil SA, Gomez D, Zhang T, Vanhems P, Koul PA, Coulibaly D, Otieno NA, Dbaibo G, Almeida MLG, Laguna-Torres VA, Drăgănescu AC, Burtseva E, Sominina A, Danilenko D, Medić S, Diez-Domingo J, Lina B. Open Forum Infect Dis. 2023 May 7;10(6):ofad244.

15. Stronger Impact of COVID-19 in Nursing Homes of a French Region During the Second Pandemic Wave. Rabilloud M, Elsensohn MH, Riche B, Voirin N, Bénet T, Porcu C, Iwaz J, Étard JF, Vanhems P, Écochard R. J Am Med Dir Assoc. 2023 Apr 21:S1525-8610(23)00378-X.

16. A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022. Guibert N, Trepat K, Pozzetto B, Josset L, Fassier JB, Allatif O, Saker K, Brengel-Pesce K, Walzer T, Vanhems P, Trouillet-Assant S; Lyon-COVID study group. Euro Surveill. 2023 Apr;28(15):2200746. 

17. Minerals and Antioxidant Micronutrients Levels and Clinical Outcome in Older Patients Hospitalized for COVID-19 during the First Wave of the Pandemic. Lahaye C, Parant F, Haesebaert J, Goldet K, Bendim'red L, Henaff L, Saadatian-Elahi M, Vanhems P, Cuerq C, Gilbert T, Blond E, Bost M, Bonnefoy M. Nutrients. 2023 Mar 21;15(6):1516.

18. Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination. Barateau V, Peyrot L, Saade C, Pozzetto B, Brengel-Pesce K, Elsensohn MH, Allatif O, Guibert N, Compagnon C, Mariano N, Chaix J, Djebali S, Fassier JB, Lina B, Lefsihane K, Espi M, Thaunat O, Marvel J, Rosa-Calatrava M, Pizzorno A, Maucort-Boulch D, Henaff L, Saadatian-Elahi M, Vanhems P, Paul S, Walzer T, Trouillet-Assant S, Defrance T. Sci Transl Med. 2023 Mar 15;15(687):eade0550.

19. One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort. Loubet P, Wittkop L, Ninove L, Chalouni M, Barrou B, Blay JY, Hourmant M, Thouvenot E, Laville M, Laviolle B, Lelievre JD, Morel J, Quoc SN, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, Circosta S, Esterle L, Levier A, Vanhems P, Tartour E, Parfait B, de Lamballerie X, Launay O; ANRS0001S COV-POPART study group. Clin Microbiol Infect. 2023 Mar;29(3):388.e1-388.e8.

20. Factors Associated with Increased or Decreased Stress Level in French Children during the First COVID-19 Lockdown. Faucher J, Khanafer N, Chauliac N, Essadek A, Galia P, Mamimoue E, Leroux ML, Pollet MP, Imler-Weber F, Gillet Y, Fourneret P, Espi P. Int J Environ Res Public Health. 2023 Mar 6;20(5):4667.

21. In-Hospital Mortality Risk Stratification in Children Under 5 Years Old with Pneumonia with or without Pulse Oximetry: A Secondary Analysis of the Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) Dataset. Hooli S, King C, McCollum ED, Colbourn T, Lufesi N, Mwansambo C, Gregory CJ, Thamthitiwat S, Cutland C, Madhi SA, Nunes MC, Gessner BD, Hazir T, Mathew JL, Addo-Yobo E, Chisaka N, Hassan M, Hibberd PL, Jeena P, Lozano JM, MacLeod WB, Patel A, Thea DM, Nguyen NTV, Zaman SM, Ruvinsky RO, Lucero M, Kartasasmita CB, Turner C, Asghar R, Banajeh S, Iqbal I, Maulen-Radovan I, Mino-Leon G, Saha SK, Santosham M, Singhi S, Awasthi S, Bavdekar A, Chou M, Nymadawa P, Pape JW, Paranhos-Baccala G, Picot VS, Rakoto-Andrianarivelo M, Rouzier V, Russomando G, Sylla M, Vanhems P, Wang J, Basnet S, Strand TA, Neuman MI, Arroyo LM, Echavarria M, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Gentile A, Chadha M, Hirve S, O'Grady KF, Clara AW, Rees CA, Campbell H, Nair H, Falconer J, Williams LJ, Horne M, Qazi SA, Nisar YB; Pneumonia REsearch Partnership to Assess WHO REcommendations (PREPARE) study group. Int J Infect Dis. 2023 Feb15: S1201-9712(23)00050-4.

22. Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022. Colosi E, Bassignana G, Barrat A, Lina B, Vanhems P, Bielicki J, Colizza V. Euro Surveill. 2023 Feb;28(5):2200192.

23. Application of a forecasting model to mitigate the consequences of unexpected RSV surge: Experience from the post-COVID-19 2021/22 winter season in a major metropolitan centre, Lyon, France. Casalegno JS, Bents S, Paget J, Gillet Y, Ploin D, Javouhey E, Lina B, Morfin F, Grenfell BT, Baker RE; VRS study group in Lyon. J Glob Health. 2023 Feb 3;13:04007.

24. Using a pharmacist-led educational interventional tool to teach elementary and middle-school students in Lebanon about microbes, antibiotic use and antimicrobial resistance: A pilot study.  K Iskandar, E Makhoul, C Haddad, D Hammoudi, S Al Khatib, I Jomha, N Khanafer, M Van Dungen, P Salameh. Pharmacy Education 2023; 23(1): 676-692.

25. Disclosure of HIV status and adherence to antiretroviral treatment in children and adolescents from Lomé and Abidjan. TA Bakai, J Iwaz, EO Takassi, A Thomas, TKF Eboua, N Khanafer, T Kenao, KB Goilibe, E Sewu, N Voirin. Pan African Medical Journal 2023;45:13.

26. Socio-economic determinants of healthy behaviours among primary schoolchildren and adolescents in Lokossa district of southern Benin. H Sagbo, P Kpodji, TA Bakai, N Khanafer. Int Health 2023;15(3):265-273.

Publications 2022

1. Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications. Martin H, Falconer J, Addo-Yobo E, Aneja S, Arroyo LM, Asghar R, Awasthi S, Banajeh S, Bari A, Basnet S, Bavdekar A, Bhandari N, Bhatnagar S, Bhutta ZA, Brooks A, Chadha M, Chisaka N, Chou M, Clara AW, Colbourn T, Cutland C, D'Acremont V, Echavarria M, Gentile A, Gessner B, Gregory CJ, Hazir T, Hibberd PL, Hirve S, Hooli S, Iqbal I, Jeena P, Kartasasmita CB, King C, Libster R, Lodha R, Lozano JM, Lucero M, Lufesi N, MacLeod WB, Madhi SA, Mathew JL, Maulen-Radovan I, McCollum ED, Mino G, Mwansambo C, Neuman MI, Nguyen NTV, Nunes MC, Nymadawa P, O'Grady KF, Pape JW, Paranhos-Baccala G, Patel A, Picot VS, Rakoto-Andrianarivelo M, Rasmussen Z, Rouzier V, Russomando G, Ruvinsky RO, Sadruddin S, Saha SK, Santosham M, Singhi S, Soofi S, Strand TA, Sylla M, Thamthitiwat S, Thea DM, Turner C, Vanhems P, Wadhwa N, Wang J, Zaman SM, Campbell H, Nair H, Qazi SA, Nisar YB; World Health Organization Pneumonia Research Partnership to Assess WHO Recommendation (PREPARE) study group. J Glob Health. 2022;12:04075.

2. Factors associated with the nutritional status of children under 5 years of age in Guinea between 2005 and 2018. Bangoura ST, Rabilloud M, Camara A, Campoy S, Condé M, Vanhems P, Kadio KJO, Touré A, Khanafer N. Public Health Nutr. 2022:1-23.

3. Predicted Impacts of Booster, Immunity Decline, Vaccination Strategies, and Non-Pharmaceutical Interventions on COVID-19 Outcomes in France.Pageaud S, Eyraud-Loisel A, Bertoglio JP, Bienvenüe A, Leboisne N, Pothier C, Rigotti C, Ponthus N, Gauchon R, Gueyffier F, Vanhems P, Iwaz J, Loisel S, Roy P, On Behalf Of The CovDyn Group Covid Dynamics.Vaccines (Basel). 2022;10(12):2033.

4. Further Cautions When Modeling the Public Health Impact of Infectious Diseases. Vanhems P, Nunes MC. Am J Public Health. 2022 ;112(11):e1-e2. 

5. Using ELEFIGHT® QR Codes for Quick Access to Information on Influenza Burden and Prevention: A Pilot Study in Lyon University Hospital. N. Khanafer, S. Oudot, C. Planckaert, N. Paquin, C. Mena, N. Trehet Mandel, R. Chapurlat, C. Lombard, G. Martin-Gaujard, L. Juillard, C. Elias, A. Janoly-Dumenil, A. Jolivot, M. Benazzouz, M. Maligeay, MP. Ayala, D. Ismail, P. Vanhems. Vaccines 2022, 10, 1591.

6. Bacterial Cross-Transmission between Inanimate Surfaces and Patients in Intensive Care Units under Real-World Conditions: A Repeated Cross-Sectional Study. Kuczewski E, Henaff L, Regard A, Argaud L, Lukaszewicz AC, Rimmelé T, Cassier P, Fredenucci I, Loeffert-Frémiot S, Khanafer N, Vanhems P. Int J Environ Res Public Health. 2022;19(15):9401.

7. COVID-19 clusters in a teaching hospital during the second wave of the SARS-CoV-2 pandemic in France: a descriptive study and lessons learned for waves to come. Dananché C, Elias C, Guibert N, Gardes S, Barreto C, Denis MA, Fascia P, Gerbier-Colomban S, Grisi B, Khanafer N, Massardier-Pilonchéry A, Munier-Marion É, Pasquet C, Fassier JB, Vanhems P. Am J Infect Control. 2022:S0196-6553(22)00505-3.

8. Protocol for a prospective quasi-experimental study on SARS-CoV-2 transmission during outdoor sports events in France: the COVID-ESO project. Elias C, Nail-Billaud S, Basset P, Laurent F, Dantony E, Fauvernier M, Roy P, Vanhems P. BMJ Open. 2022;12(6):e055927.

9. National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance. de Fougerolles TR, Damm O, Ansaldi F, Chironna M, Crépey P, de Lusignan S, Gray I, Guillen JM, Kassianos G, Mosnier A, de Lejarazu RO, Pariani E, Puig-Barbera J, Schelling J, Trippi F, Vanhems P, Wahle K, Watkins J, Rasuli A, Vitoux O, Bricout H. BMC Public Health. 2022;22(1):1151.

10. Attributable Mortality of Ventilator-associated Pneumonia Among COVID-19 Patients. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Comparot S, Courno G, Vanhems P, Landel V, Lavigne T, Bailly S, Bettega F, Study Group RR, Maucort-Boulch D, Friggeri A. Am J Respir Crit Care Med. 2022 doi: 10.1164/rccm.202202-0357OC.

11. Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation. Parant F, Bouloy J, Haesebaert J, Bendim'red L, Goldet K, Vanhems P, Henaff L, Gilbert T, Cuerq C, Blond E, Bost M, Bonnefoy M. Nutrients. 2022;14(8):1641.

12. Derivation and validation of a novel risk assessment tool to identify children aged 2-59 months at risk of hospitalised pneumonia-related mortality in 20 countries. Rees CA, Colbourn T, Hooli S, King C, Lufesi N, McCollum ED, Mwansambo C, Cutland C, Madhi SA, Nunes M, Matthew JL, Addo-Yobo E, Chisaka N, Hassan M, Hibberd PL, Jeena PM, Lozano JM, MacLeod WB, Patel A, Thea DM, Nguyen NTV, Kartasasmita CB, Lucero M, Awasthi S, Bavdekar A, Chou M, Nymadawa P, Pape JW, Paranhos-Baccala G, Picot VS, Rakoto-Andrianarivelo M, Rouzier V, Russomando G, Sylla M, Vanhems P, Wang J, Asghar R, Banajeh S, Iqbal I, Maulen-Radovan I, Mino-Leon G, Saha SK, Santosham M, Singhi S, Basnet S, Strand TA, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Clara AW, Campbell H, Nair H, Falconer J, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group. BMJ Glob Health. 2022;7(4):e008143

13. Effect of influenza vaccination among healthcare workers on hospital-acquired influenza in short-stay hospitalized patients: A multicenter pilot study in France. Amour S, Bénet T, Regis C, Robert O, Fontana L, Lina B, Pozzetto B, Berthelot P, Vanhems P. Infect Control Hosp Epidemiol. 2022:1-5. doi: 10.1017/ice.2022.68.

14. Undernourished patients do not have increased risk of severe COVID-19 outcomes. Fneich A, Poinsot P, Elias C, Restier L, Vanhems P, Wallet F, Caussy C, Duclos A, Peretti N. Clin Nutr Open Sci. 2022 doi: 10.1016/j.nutos.2022.03.002.

15. T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19. Venet F, Gossez M, Bidar F, Bodinier M, Coudereau R, Lukaszewicz AC, Tardiveau C, Brengel-Pesce K, Cheynet V, Cazalis MA, Pescarmona R, Garnier L, Ortillon M, Buisson M, Bouscambert-Duchamp M, Morfin-Sherpa F, Casalegno JS, Conti F, Rimmelé T, Argaud L, Cour M, Saadatian-Elahi M, Henaff L, Vanhems P, Monneret G; RICO study group. EBioMedicine. 2022;78:103967.

16. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Rigoine de Fougerolles T, Puig-Barbera J, Kassianos G, Vanhems P, Schelling J, Crepey P, de Lejarazu RO, Ansaldi F, Fruhwein M, Galli C, Mosnier A, Pariani E, Rasuli A, Vitoux O, Watkins J, Weinke T, Bricout H. Influenza Other Respir Viruses. 2022;16(3):417-428.

17. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study. Luque-Paz D, Tattevin P, Loubet P, Bénézit F, Thibault V, Lainé F, Vanhems P, Amour S, Lina B, Duval X, L'Honneur AS, Fidouh N, Vallejo C, Alain S, Galtier F, Foulongne V, Lagathu G, Lenzi N, Lesieur Z, Launay O, Jouneau S; FLUVAC Study Group. Sci Rep. 2022;12(1):4199.

18. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A; REA-REZO Study Group. Crit Care Med. 2022;50(3):449-459.

19. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study. Descamps A, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Amour S, L'Honneur AS, Fidouh N, Foulongne V, Lagathu G, Duval X, Merle C, Lina B, Carrat F, Launay O, Loubet P; FLUVAC study group. Eur Respir J. 2022;59(3):2100651.

20. Nasopharyngeal Viral and Bacterial Co-Detection among Children from Low- and Middle-Income Countries with and without Pneumonia. Dananché C, Paranhos-Baccalà G, Messaoudi M, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Wang J, Sanghavi S, Diallo S, Chou M, Eap T, Rakoto-Andrianarivelo M, Endtz H, Ren L, Dash-Yandag B, Guillen R, Nymadawa P, Russomando G, Komurian-Pradel F, Vanhems P, Picot VS; Pneumonia Global Approach for Biological Research, Infectious Diseases and Epidemics in Low-Income Countries (GABRIEL) Network. Am J Trop Med Hyg. 2022:tpmd210980.

21. COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study. Romain-Scelle N, Elias C, Vanhems P. Vaccine. 2022;40(5):695-700.

22. COVID-19 outbreaks in nursing homes: A strong link with the coronavirus spread in the surrounding population, France, March to July 2020. Rabilloud M, Riche B, Etard JF, Elsensohn MH, Voirin N, Bénet T, Iwaz J, Ecochard R, Vanhems P. PLoS One. 2022;17(1):e0261756.

23. Baseline clinical features of COVID-19 patients, delay of hospital admission and clinical outcome: A complex relationship. Dananché C, Elias C, Hénaff L, Amour S, Kuczewski E, Gustin MP, Escuret V, Saadatian-Elahi M, Vanhems P. PLoS One. 2022;17(1):e0261428.

24. Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019. Dessemon J, Elias C, Henaff L, Saadatian-Elahi M, Vanhems P. Open Forum Infect Dis. 2022;9(1):ofab580.

25. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study. Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O; FLUVAC Study group. Infect Dis Now. 2022;52(1):40-43.

26. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Loubet P, Wittkop L, Ninove L, Chalouni M, Barrou B, Blay JY, Hourmant M, Thouvenot E, Laville M, Laviolle B, Lelievre JD, Morel J, Quoc SN, Spano JP, Terrier B, Thiebaut A, Viallard JF, Vrtovsnik F, Circosta S, Esterle L, Levier A, Vanhems P, Tartour E, Parfait B, de Lamballerie X, Launay O; ANRS0001S COV-POPART study group. Clin Microbiol Infect. 2022 14: S1198-743X(22)00522-5.

Publications 2021

1. COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhône-Alpes region (France): An ecological study. Romain-Scelle N, Elias C, Vanhems P. Vaccine. 2021 Dec 22: S0264-410X(21)01644-3.

2. Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures. Pageaud S, Pothier C, Rigotti C, Eyraud-Loisel A, Bertoglio JP, Bienvenüe A, Leboisne N, Ponthus N, Gauchon R, Gueyffier F, Vanhems P, Iwaz J, Loisel S, Roy P, On Behalf Of The Group CovDyn Covid Dynamics. Vaccines (Basel). 2021 Dec 10;9(12):1462.

3. Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control study. Luong Ngyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O; FLUVAC Study group. Infect Dis Now. 2021 Dec 15: S2666-9919(21)00547-9.

4. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Rigoine de Fougerolles T, Puig-Barbera J, Kassianos G, Vanhems P, Schelling J, Crepey P, de Lejarazu RO, Ansaldi F, Fruhwein M, Galli C, Mosnier A, Pariani E, Rasuli A, Vitoux O, Watkins J, Weinke T, Bricout H. Influenza Other Respir Viruses. 2021 Dec 5. doi: 10.1111/irv.12941

5. External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia. Rees CA, Hooli S, King C, McCollum ED, Colbourn T, Lufesi N, Mwansambo C, Lazzerini M, Madhi SA, Cutland C, Nunes M, Gessner BD, Basnet S, Kartasasmita CB, Mathew JL, Zaman SMAU, Paranhos-Baccala G, Bhatnagar S, Wadhwa N, Lodha R, Aneja S, Santosham M, Picot VS, Sylla M, Awasthi S, Bavdekar A, Pape JW, Rouzier V, Chou M, Rakoto-Andrianarivelo M, Wang J, Nymadawa P, Vanhems P, Russomando G, Asghar R, Banajeh S, Iqbal I, MacLeod W, Maulen-Radovan I, Mino G, Saha S, Singhi S, Thea DM, Clara AW, Campbell H, Nair H, Falconer J, Williams LJ, Horne M, Strand T, Qazi SA, Nisar YB, Neuman MI; World Health Organization PREPARE study group48. J Glob Health. 2021;11:04062. doi: 10.7189/jogh.11.04062. eCollection 2021.

6. Psychological impact of an acute intervention on medical-psychological emergency unit professionals: the example of hurricane Irma. Razakarivony O, Khanafer N, Philippe JM, Prieto N. BJPsych Open. 2021;7(4):e113

7. The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. Daou F, Abou-Sleymane G, Badro DA, Khanafer N, Tobaiqy M, Al Faraj A. Int J Environ Res Public Health. 2021;18(3):955

8. Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes. El Guerche-Séblain C, Chakir L, Nageshwaran G, Harris RC, Sevoz-Couche C, Vitoux O, Vanhems P. Travel Med Infect Dis. 2021;44:102171. doi: 10.1016/j.tmaid.2021.102171. 

9. Increased Incidence of Ventilator-Acquired Pneumonia in Coronavirus Disease 2019 Patients: A Multicentric Cohort Study. Vacheron CH, Lepape A, Savey A, Machut A, Timsit JF, Vanhems P, Le QV, Egbeola J, Martin M, Maxime V, Pugliesi PS, Maucort-Boulch D, Friggeri A; REA-REZO Study Group. Crit Care Med. 2021 doi:10.1097/CCM.0000000000005297.

10. Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control. El Guerche-Séblain C, Rigoine De Fougerolles T, Sampson K, Jennings L, Van Buynder P, Shu Y, Sekawi Z, Yee-Sin L, Walls T, Vitoux O, Yin JK, Wong A, Schellevis F, Vanhems P. BMC Public Health. 2021;21(1):1750.

11. Incidence of hospital-acquired influenza in adults: A prospective surveillance study from 2004 to 2017 in a French tertiary care hospital. El Guerche-Séblain C, Amour S, Bénet T, Hénaff L, Escuret V, Schellevis F, Vanhems P. Am J Infect Control. 2021;49(8):1066-1071.

12. In-hospital and midterm out-hospital complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study. Descamps A, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Amour S, L'Honneur AS, Fidouh N, Foulongne V, Lagathu G, Duval X, Merle C, Lina B, Carrat F, Launay O, Loubet P; FLUVAC study group. Eur Respir J. 2021:2100651.

13. Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia. Lakbar I, Medam S, Ronflé R, Cassir N, Delamarre L, Hammad E, Lopez A, Lepape A, Machut A, Boucekine M, Zieleskiewicz L, Baumstarck K, Savey A, Leone M; REA RAISIN Study Group. Sci Rep. 2021;11(1):16497.

14. Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France. Saadatian-Elahi M, Amour S, Elias C, Henaff L, Dananché C, Vanhems P. J Med Virol. 2021 :10.1002/jmv.27233. 

15. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital. Khanafer N, Vanhems P, Bennia S, Martin-Gaujard G, Juillard L, Rimmelé T, Argaud L, Martin O, Huriaux L, Marcotte G, Hernu R, Floccard B, Cassier P, Group S. Int J Environ Res Public Health. 2021;18(14):7528. 

16. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France. Casalegno JS, Ploin D, Cantais A, Masson E, Bard E, Valette M, Fanget R, Targe SC, Myar-Dury AF, Doret-Dion M, Massoud M, Queromes G, Vanhems P, Claris O, Butin M, Pillet S, Ader F, Bin S, Gaymard A, Lina B, Morfin F; VRS study group in Lyon, Javouhey E, Gillet Y. Euro Surveill. 2021;26(29). 

17. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Van Summeren J, Meijer A, Aspelund G, Casalegno JS, Erna G, Hoang U, Lina B; VRS study group in Lyon, de Lusignan S, Teirlinck AC, Thors V, Paget J. Euro Surveill. 2021;26(29). 

18. A breath of humanity in the era of Covid-19 vaccine. P. Vanhems. Vaccine. 2021; 39(28): 3649

19. Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network. Lepape A, Machut A, Gerbier-Colomban S, Kuczewski E, Rasigade JP, Timsit JF, Vanhems P, Wallet F, Savey A, Friggeri A; REA-REZO Group. J Hosp Infect. 2021; 115:1-4

20. Trends in the proportion of resistant bacteria involved in ventilator-associated pneumonia as the first hospital-acquired infection in intensive care units between 2003 and 2016 in Lyon, France. Teoli J, Amour S, Dananché C, Dauwalder O, Gerbier-Colomban S, Mauranne CC, Zorio V, Monard C, Arnal S, Friggeri A, Lepape A, Guerin C, Rimmelé T, Argaud L, Munier-Marion E, Gustin MP, Vanhems P. Am J Infect Control. 2021: S0196-6553(21)00273-X 

21. Prognostic factors of severe community-acquired staphylococcal pneumonia in France. Gillet Y, Tristan A, Rasigade JP, Saadatian-Elahi M, Bouchiat C, Bes M, Dumitrescu O, Leloire M, Dupieux C, Laurent F, Lina G, Etienne J, Vanhems P, Argaud L, Vandenesch F; PVL pneumonia study group. Eur Respir J. 2021:2004445

22. Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study. Czepiel J, Krutova M, Mizrahi A, Khanafer N, Enoch DA, Patyi M, Deptuła A, Agodi A, Nuvials X, Pituch H, Wójcik-Bugajska M, Filipczak-Bryniarska I, Brzozowski B, Krzanowski M, Konturek K, Fedewicz M, Michalak M, Monpierre L, Vanhems P, Gouliouris T, Jurczyszyn A, Goldman-Mazur S, Wultańska D, Kuijper EJ, Skupień J, Biesiada G, Garlicki A. Antibiotics (Basel). 2021;10(3):299

23.The COVID-19 pandemic is deepening the health crisis in South Kivu. Écochard R, Wimba P, Bengehya J, Bianga PK, Lugwarha S, Oyimangirwe M, Bazeboso JA, Tshilolo L, Longo-Mbenza B, Rabilloud M, Iwaz J, Étard JF, Vanhems P. Int J Infect Dis. 2021: S1201-9712(21)00261-7

24. Incubation period of COVID-19: a meta-analysis. Elias C, Sekri A, Leblanc P, Cucherat M, Vanhems P. Int J Infect Dis. 2021;104 :708-10

25. Establishment of a French surveillance system of Clostridiodes difficile infection: comparison of patient’s characteristics with other national and European data. Khanafer N, Hemmendinger A, Guery B, Vachee A, Rogues AM, Gravet A, Boutoille D, Vanjak D, Barbut F, Vanhems P. Anaerobes 2021; 69:102329

26. Factors associated with admission to intensive care units in COVID-19 patients in Lyon-France. Vanhems P, Gustin MP, Elias C, Hénaff L, Dananché C, Grisi B, Marion E, Khanafer N, Hilliquin D, Gardes S, Gerbier-Colomban S, Amour S, Kuczewski E, Escuret V, Lina B, Saadatian-Elahi M, COVID-Outcomes-HCL Consortium. PLoS One 2021;16(1):e0243709

27. Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study. Bénet T, Amour S, Valette M, Saadatian-Elahi M, Aho-Glélé LS, Berthelot P, Denis MA, Grando J, Landelle C, Astruc K, Paris A, Pillet S, Lina B, Vanhems P; AFP Study Group. Clin Infect Dis. 2021;72(9):e311-e318

28. A conceptual discussion about the basic reproduction number of Severe Acute Respiratory Syndrome Coronavirus 2 in healthcare settings.Temime L, Gustin MP, Duval A, Buetti N, Crépey P, Guillemot D, Thiébaut R, Vanhems P, Zahar JR, Smith DRM, Opatowski L. Clin Infect Dis. 2021;72(1):141-143

29. Characteristics of human pneumovirus infection in adults hospitalized community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study. Loubet P, Mathieu P, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Duval X, Postil D, Amour S, Rogez S, Lagathu G, L’Honneur AS, Foulongne V, Houhou N, Lina B, Carrat F, Launay O; Fluvac study group. Clin Microbiol Infect. 2021;27(1):127.e1-127.e6